Lv3
388 积分 2025-07-31 加入
Long-Term Care Insurance and Catastrophic Health Spending at the End of Life Among Older Adults: Evidence From China
7小时前
待确认
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
2天前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
25天前
已完结
Valuing Health States for Use in Cost-Effectiveness Analysis
29天前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
1个月前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
1个月前
已完结
Developing a patient-based utility value set for the EORTC QLU-C10D using the OPUF method in Chinese cancer patients
1个月前
已完结
Mapping Patient-Reported Outcomes Measurement Information System Pediatric-25 Profile to EQ-5D-Y-3L
1个月前
已关闭
Methodological Insights From Health Valuation Studies in Low- and Middle-Income Countries: A Scoping Review
1个月前
已关闭
A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index
1个月前
已完结
皖公网安备34019202002308
